Re:Thanks, HN: You helped discover a disease and save lives
by davecap1 on Friday July 18, 2014 @10:44AM
(#8053260)
Hi Hiren, just wanted to let you know about SolveBio (I'm the CTO). Our goal is to compile the world's clinically relevant biological reference data and to help people build genomics applications. Right now we offer REST APIs to some widely used genomics datasets (such as ClinVar, Uniprot) and some others like Medline. I'd love to hear more about the work you're doing, and see if there are any ways we can help!
Re:Thanks, HN: You helped discover a disease and save lives
by mattmight on Friday July 18, 2014 @11:25AM
(#8053519)
Hi Hiren!
Thanks again for meeting with me after the original post!
Please send me a link to the pages once they're up.
What you're doing is really critical. I've discovered that a lot of non-glycobiologists 'shut down' when it comes to glycobiology.
Certainly in the case of one earlier NGLY1 patient, that caused the NGLY1 mutation to go overlooked until they found my blog post.
A resource like what you're creating will be incredibly valuable for the wider CDG and non-glyco community.
Thanks!
Re:Thanks, HN: You helped discover a disease and save lives
by hirenj on Friday July 18, 2014 @03:56PM
(#8055251)
I will do so! They'll be short on content to start with, since we've still got to do the leg work to fill in the data.
I don't really get why other biologists shut down, but I figure if we put together some good cognitive (and analytical) tools to allow people to better understand the roles of glycosylation, it'll no longer be so scary.
I figure I should chime in here with some info about glycobiology and disease.
The issue of rare diseases highlights an issue with disease discovery, in that techniques such as GWAS don't really have the power to identify these rare diseases, and that our current pipelines to find these diseases won't really work. Searching for these disease associations is a bit like looking for a needle in a series of small independent haystacks that may or may not share hay. Since our gut feeling with glycobiology is that we are talking about mostly rare diseases or subtle phenotypes, our goal is to use more of an integrated approach (taking data from many -omics strategies) to try and pinpoint subsystems that are affected by disease.
Concretely, we're trying to expand outreach with our knowledge of mutations in glycosylation related genes, and we should be submitting a manuscript next week on the start of our work trying to find some of these relevant rarer mutations. It'll be coupled with some web pages (right after I find some time to generate them), that make it a bit easier for non-glycobiologists to get information out about these genes. The larger and more comprehensive this resource is, the better.
The ubiquity of sequencing data that is coming out now is making a huge difference in our field. One challenge, as mentioned below, is getting centralised access to all this data. If anyone knows of a great bit of software where I can feed in data from various exome sequencing populations, that has a REST api for retrieving variants (and ideally amino acid changes) I would be interested to hear of this, since it will save me time writing it myself.
As an aside - there was an article that floated off the front page here about blood types, and why we have them, and is another example of the relevance of glycobiology, and the difficulty in understanding mutations. Basically for the blood type gene, you can have single variation causing a single amino acid change pretty much all over the gene, and they all very subtly (or not so subtly) alter the activity of the gene. To pick out which one of the variations is deleterious is not trivial.
In the field of glycobiology, there's still a lot of work to do, but I think we're making some progress, and I hope we can actually unlock some secrets, and give help to people soon.